Qualitative study exploring the design of a patient-reported symptom-based risk stratification system for suspected head and neck cancer referrals: protocol for work packages 1 and 2 within the EVEREST-HN programme.

Autor:	Albutt A; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Hardman J; Northwick Park Hospital, London, UK., McVey L; Centre for Digital Innovations in Health & Social Care, University of Bradford, Bradford, UK.; Wolfson Centre for Applied Health Research, Bradford, UK., Odo C; Centre for Digital Innovations in Health & Social Care, University of Bradford, Bradford, UK.; Wolfson Centre for Applied Health Research, Bradford, UK., Paleri V; The Royal Marsden NHS Foundation Trust, London, UK., Patterson J; University of Liverpool, Liverpool, UK., Webb S; The Royal Marsden NHS Foundation Trust, London, UK., Rousseau N; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Kellar I; Department of Psychology, The University of Sheffield, Sheffield, UK., Randell R; Centre for Digital Innovations in Health & Social Care, University of Bradford, Bradford, UK r.randell@bradford.ac.uk.; Wolfson Centre for Applied Health Research, Bradford, UK.
Jazyk:	angličtina
Zdroj:	BMJ open [BMJ Open] 2024 Apr 05; Vol. 14 (4), pp. e081151. Date of Electronic Publication: 2024 Apr 05.
DOI:	10.1136/bmjopen-2023-081151
Abstrakt:	Introduction: Between 2009/2010 and 2019/2020, England witnessed an increase in suspected head and neck cancer (sHNC) referrals from 140 to 404 patients per 100 000 population. 1 in 10 patients are not seen within the 2-week target, contributing to patient anxiety. We will develop a pathway for sHNC referrals, based on the Head and Neck Cancer Risk Calculator. The evolution of a patient-reported symptom-based risk stratification system to redesign the sHNC referral pathway (EVEREST-HN) Programme comprises six work packages (WPs). This protocol describes WP1 and WP2. WP1 will obtain an understanding of language to optimise the SYmptom iNput Clinical (SYNC) system patient-reported symptom questionnaire for sHNC referrals and outline requirements for the SYNC system. WP2 will codesign key elements of the SYNC system, including the SYNC Questionnaire, and accompanying behaviour change materials. Methods and Analysis: WP1 will be conducted at three acute National Health Service (NHS) trusts with variation in service delivery models and ensuring a broad mixture of social, economic and cultural backgrounds of participants. Up to 150 patients with sHNC (n=50 per site) and 15 clinicians (n=5 per site) will be recruited. WP1 will use qualitative methods including interviews, observation and recordings of consultations. Rapid qualitative analysis and inductive thematic analysis will be used to analyse the data. WP2 will recruit lay patient representatives to participate in online focus groups (n=8 per focus group), think-aloud technique and experience-based codesign and will be analysed using qualitative and quantitative approaches. Ethics and Dissemination: The committee for clinical research at The Royal Marsden, a research ethics committee and the Health Research Authority approved this protocol. All participants will give informed consent. Ethical issues of working with patients on an urgent cancer diagnostic pathway have been considered. Findings will be disseminated via journal publications, conference presentations and public engagement activities. Competing Interests: Competing interests: None declared. (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu